Reduced ATR or Chk1 expression leads to chromosome instability and chemosensitization of mismatch repair-deficient colorectal cancer cells.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Biology of the Cell

• Publication date

  2009-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1091/mbc.E09-04-0303PMID 19570909PMCID PMC2735479
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic polymorphisms and micronucleus formation: a review of the literature.

  2008cited by this paper
• Regulation of p53 Expression in Response to 5-Fluorouracil in Human Cancer RKO Cells

  2007cited by this paper
• Characterization of the Interactome of the Human MutL Homologues MLH1, PMS1, and PMS2*

  2007cited by this paper
• The genetics of hereditary colon cancer.

  2007cited by this paper
• Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks

  2007cited by this paper
• Mutations in the ataxia telangiectasia and rad3‐related–checkpoint kinase 1 DNA damage response axis in colon cancers

  2007cited by this paper
• Chk1 frameshift mutation in sporadic and hereditary non-polyposis colorectal cancers with microsatellite instability.

  2007cited by this paper
• Endonucleolytic Function of MutLα in Human Mismatch Repair

  2006cited by this paper
• ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts.

  2006cited by this paper
• Common fragile sites as targets for chromosome rearrangements.

  2006cited by this paper
• Signalling cell cycle arrest and cell death through the MMR System.

  2006cited by this paper
• ATR Kinase Activation Mediated by MutSα and MutLα in Response to Cytotoxic O6-Methylguanine Adducts

  2006cited by this paper
• Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites

  2006cited by this paper
• The multifaceted mismatch-repair system

  2006cited by this paper
• Endonucleolytic function of MutLalpha in human mismatch repair.

  2006cited by this paper
• DNA Mismatch Repair-dependent Response to Fluoropyrimidine-generated Damage*

  2005cited by this paper
• Mutational Targets in Colorectal Cancer Cells with Microsatellite Instability

  2005cited by this paper
• The Relationship between Global Methylation Level, Loss of Heterozygosity, and Microsatellite Instability in Sporadic Colorectal Cancer

  2005cited by this paper
• Centrosome amplification, chromosome instability and cancer development.

  2005cited by this paper
• Heterozygous ATR mutations in mismatch repair-deficient cancer cells have functional significance.

  2005cited by this paper
• Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2.

  2005cited by this paper
• Chromosomal instability and APC gene mutations in human sporadic colorectal adenomas

  2004cited by this paper
• ATM-Mediated Stabilization of hMutL DNA Mismatch Repair Proteins Augments p53 Activation during DNA Damage

  2004cited by this paper
• Mismatch repair-mediated G2/M arrest by 6-thioguanine involves the ATR-Chk1 pathway.

  2004cited by this paper
• ATR functions as a gene dosage‐dependent tumor suppressor on a mismatch repair‐deficient background

  2004cited by this paper
• Role of hMLH1 promoter hypermethylation in drug resistance to 5‐fluorouracil in colorectal cancer cell lines

  2003cited by this paper
• The significance of unstable chromosomes in colorectal cancer

  2003influential reference
• The mismatch repair system is required for S-phase checkpoint activation

  2003cited by this paper
• ATM and related protein kinases: safeguarding genome integrity

  2003cited by this paper
• MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation

  2003cited by this paper
• A role for DNA mismatch repair in sensing and responding to fluoropyrimidine damage

  2003cited by this paper
• Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level

  2002cited by this paper
• Mutations within the hMLH1 and hPMS2 Subunits of the Human MutLα Mismatch Repair Factor Affect Its ATPase Activity, but Not Its Ability to Interact with hMutSα*

  2002cited by this paper
• The role of chromosomal instability in tumor initiation

  2002cited by this paper
• A systematic overview of chemotherapy effects in colorectal cancer.

  2001cited by this paper
• Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability.

  2001cited by this paper
• Cell cycle checkpoint signaling through the ATM and ATR kinases.

  2001cited by this paper
• Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.

  2001influential reference
• Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice.

  2000cited by this paper
• Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice.

  2000influential reference
• Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

  2000cited by this paper
• Cytogenetic characterization of two colon cell lines by using conventional G-banding, comparative genomic hybridization, and whole chromosome painting.

  2000cited by this paper
• ATR disruption leads to chromosomal fragmentation and early embryonic lethality.

  2000cited by this paper
• DNA mismatch repair and genetic instability.

  2000cited by this paper
• Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DMA mismatch repair

  1998cited by this paper
• Genetic instability in colorectal cancers

  1997cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper
• Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation.

  1994cited by this paper
• Radiosensitivity in ataxia-telangiectasia: a new explanation.

  1980cited by this paper

• Early mutational events and clonal dynamics in normal crypts: implications for colorectal tumorigenesis

  2025cites this paper
• Identification of DNA Repair-related Genes as Biomarkers Reflecting MSI, TMB, and TIL in Colorectal Cancer

  2024cites this paper
• REV3 promotes cellular tolerance to 5-fluorodeoxyuridine by activating translesion DNA synthesis and intra-S checkpoint

  2024cites this paper
• DNA mismatch repair in cancer immunotherapy

  2023cites this paper
• ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway

  2023cites this paper
• Immunosuppressive Signaling Pathways as Targeted Cancer Therapies

  2022cites this paper
• ATR-I774Yfs*5 promotes genomic instability through micronuclei formation

  2022cites this paper
• Knockdown of DNA‐binding protein A enhances the chemotherapy sensitivity of colorectal cancer via suppressing the Wnt/β‐catenin/Chk1 pathway

  2020cites this paper
• MLH1 Deficiency-Triggered DNA Hyperexcision by Exonuclease 1 Activates the cGAS-STING Pathway.

  2020influential citation
• FLT3-ITD cooperates with Rac1 to modulate the sensitivity of leukemic cells to chemotherapeutic agents via regulation of DNA repair pathways

  2019cites this paper
• DNA damage response and repair in colorectal cancer: Defects, regulation and therapeutic implications.

  2018cites this paper
• Colonic Lysine Homocysteinylation Induced by High-Fat Diet Suppresses DNA Damage Repair.

  2018cites this paper
• DNA Damage Response-Independent Role for MDC1 in Maintaining Genomic Stability

  2017cites this paper
• Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells

  2016cites this paper
• Zbtb1 Safeguards Genome Integrity and Prevents p53-Mediated Apoptosis in Proliferating Lymphoid Progenitors

  2016cites this paper
• Phase I study of LY2603618, a CHK1 inhibitor, in combination with gemcitabine in Japanese patients with solid tumors

  2015cites this paper
• Trial Watch: Targeting ATM–CHK2 and ATR–CHK1 pathways for anticancer therapy

  2015cites this paper
• Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance.

  2015cites this paper
• Characterising the phosphorylation of YB-1

  2015cites this paper
• Investigating the role of CK2 in the DNA damage response

  2014cites this paper
• Targeting ATR in DNA damage response and cancer therapeutics.

  2014cites this paper
• Distinct Gene Expression Signatures in Lynch Syndrome and Familial Colorectal Cancer Type X

  2013cites this paper
• The interaction between Rad9 and Tousled-like kinase 1 in the cell cycle and the DNA damage response

  2013cites this paper
• Identification of DNA Repair Pathways That Affect the Survival of Ovarian Cancer Cells Treated with a Poly(ADP-Ribose) Polymerase Inhibitor in a Novel Drug Combination

  2012influential citation
• Selective tumor killing based on specific DNA-damage response deficiencies

  2012cites this paper
• Identification of DNA repair pathways that affect the survival of ovarian cancer cells treated with a PARP inhibitor in a novel drug combination

  2012influential citation
• ATR (ataxia telangiectasia and Rad3 related)

  2011cites this paper
• Analysis of Mutations That Dissociate G2 and Essential S Phase Functions of Human Ataxia Telangiectasia-mutated and Rad3-related (ATR) Protein Kinase*

  2011cites this paper
• Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening

  2011cites this paper
• Checkpoint Signaling, Base Excision Repair, and PARP Promote Survival of Colon Cancer Cells Treated with 5-Fluorodeoxyuridine but Not 5-Fluorouracil

  2011cites this paper
• Persimmon Leaf Extract Inhibits the ATM Activity during DNA Damage Response Induced by Doxorubicin in A549 Lung Adenocarcinoma Cells

  2011cites this paper
• Single-agent inhibition of Chk1 is antiproliferative in human cancer cell lines in vitro and inhibits tumor xenograft growth in vivo.

  2011cites this paper
• P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance

  2011influential citation
• Glucose deprivation is associated with Chk1 degradation through the ubiquitin-proteasome pathway and effective checkpoint response to replication blocks.

  2011cites this paper
• Poly(ADP-Ribose) polymerase inhibition synergizes with 5-fluorodeoxyuridine but not 5-fluorouracil in ovarian cancer cells.

  2011cites this paper
• Prospects for the Use of ATR Inhibitors to Treat Cancer

  2010cites this paper
• Roles For The Dna Damage Checkpoint Protein Hus1 In Tissue Homeostasis And Tumor Suppression

  2010cites this paper